Europace Advance Access published online on July 17, 2007
Europace, doi:10.1093/europace/eum131
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL ARTICLE
Repolarization variability in the risk stratification of MADIT II patients
1 Heart Research Follow-up Program, Cardiology, University of Rochester Medical Center, Box 653 Rochester, NY 14642, USA; 2 Hopital Lariboisière, Paris, France; 3 Ela Medical, Paris, France
Aims QT variability has been reported to be associated with ventricular arrhythmias and sudden cardiac death. There is limited data regarding variability in T-wave morphology and its prognostic value. In this study, we present a novel approach for the measurement of T-wave variability (TWV) reflecting changes in T-wave morphology, and we investigate the prognostic significance of Holter-derived TWV in patients with and without ventricular arrhythmias requiring appropriate implantable cardioverter defibrillator (ICD) therapy from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II).
Methods Study population consisted of 275 ICD patients from MADIT II after excluding patients with intraventricular conduction abnormalities or atrial fibrillation. TWV was measured based on amplitude variance of T-wave amplitude.
Results During 2-year follow-up, 58 (21%) patients had appropriate ICD therapy for ventricular tachycardia or fibrillation. Patients with appropriate ICD therapy had higher levels of TWV measures than those without arrhythmic events. After adjustment for heart rate, ejection fraction, and significant clinical predictors of arrhythmic events, a Cox proportional-hazards regression model revealed that dichotomized TWV values were predictive for ventricular tachyarrhythmias requiring appropriate ICD therapy (hazard ratio, 2.0; 95% CI; 1.2–3.5; P = 0.01). On the basis of the comprehensive testing, TWV value >59 µV was found predictive for arrhythmic events in MADIT II population.
Conclusion Our newly designed method for the assessment of repolarization variability in ambulatory Holter recordings detected transient variability of T-wave morphology, which was predictive for ventricular tachyarrhythmias in the MADIT II population.
Key Words: T-wave variability, MADIT II, Risk stratification
* Corresponding author. Tel: +1 585 275 1096; fax: +1 585 273 5283. E-mail address: jean-philippe.couderc{at}heart.rochester.edu
Manuscript submitted 26 February 2007. Accepted after revision 12 June 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-P. Couderc Measurement and regulation of cardiac ventricular repolarization: from the QT interval to repolarization morphology Phil Trans R Soc A, April 13, 2009; 367(1892): 1283 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Korhonen, T. Husa, T. Konttila, I. Tierala, M. Makijarvi, H. Vaananen, and L. Toivonen Complex T-wave morphology in body surface potential mapping in prediction of arrhythmic events in patients with acute myocardial infarction and cardiac dysfunction Europace, April 1, 2009; 11(4): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Rashba, G. A. Lamas, J.-P. Couderc, S. M. Hollist, V. Dzavik, W. Ruzyllo, V. Fridrich, C. E. Buller, S. A. Forman, J. A. Kufera, et al. Electrophysiological Effects of Late Percutaneous Coronary Intervention for Infarct-Related Coronary Artery Occlusion: The Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP) Circulation, February 17, 2009; 119(6): 779 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pueyo, J. P. Martinez, and P. Laguna Cardiac repolarization analysis using the surface electrocardiogram Phil Trans R Soc A, January 28, 2009; 367(1887): 213 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes J. Clin. Pharmacol., January 1, 2009; 49(1): 6 - 16. [Abstract] [Full Text] [PDF] |
||||



